Skip to main content
Top
Published in: International Journal of Legal Medicine 5/2021

Open Access 01-09-2021 | Autopsy | Original Article

Infectivity of deceased COVID-19 patients

Authors: Stefanie Plenzig, D. Bojkova, H. Held, A. Berger, F. Holz, J. Cinatl, E. Gradhand, M. Kettner, A. Pfeiffer, M. A. Verhoff, S. Ciesek

Published in: International Journal of Legal Medicine | Issue 5/2021

Login to get access

Abstract

The duration of infectivity of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) in living patients has been demarcated. In contrast, a possible SARS-CoV-2 infectivity of corpses and subsequently its duration under post mortem circumstances remain to be elucidated. The aim of this study was to investigate the infectivity and its duration of deceased COVID-19 (coronavirus disease) patients. Four SARS-CoV-2 infected deceased patients were subjected to medicolegal autopsy. Post mortem intervals (PMI) of 1, 4, 9 and 17 days, respectively, were documented. During autopsy, swabs and organ samples were taken and examined by RT-qPCR (real-time reverse transcription-polymerase chain reaction) for the detection of SARS-CoV-2 ribonucleic acid (RNA). Determination of infectivity was performed by means of virus isolation in cell culture. In two cases, virus isolation was successful for swabs and tissue samples of the respiratory tract (PMI 4 and 17 days). The two infectious cases showed a shorter duration of COVID-19 until death than the two non-infectious cases (2 and 11 days, respectively, compared to > 19 days), which correlates with studies of living patients, in which infectivity could be narrowed to about 6 days before to 12 days after symptom onset. Most notably, infectivity was still present in one of the COVID-19 corpses after a post-mortem interval of 17 days and despite already visible signs of decomposition. To prevent SARS-CoV-2 infections in all professional groups involved in the handling and examination of COVID-19 corpses, adequate personal safety standards (reducing or avoiding aerosol formation and wearing FFP3 [filtering face piece class 3] masks) have to be enforced for routine procedures.
Literature
2.
go back to reference Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 55(3):105924CrossRef Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 55(3):105924CrossRef
3.
go back to reference Wichmann D, Sperhake JP, Lütgehetmann M, Steurer S, Edler C, Heinemann A, Heinrich F, Mushumba H, Kniep I, Schröder AS, Burdelski C, de Heer G, Nierhaus A, Frings D, Pfefferle S, Becker H, Bredereke-Wiedling H, de Weerth A, Paschen HR, Sheikhzadeh-Eggers S, Stang A, Schmiedel S, Bokemeyer C, Addo MM, Aepfelbacher M, Püschel K, Kluge S (2020) Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann Intern Med 173(4):268–277CrossRef Wichmann D, Sperhake JP, Lütgehetmann M, Steurer S, Edler C, Heinemann A, Heinrich F, Mushumba H, Kniep I, Schröder AS, Burdelski C, de Heer G, Nierhaus A, Frings D, Pfefferle S, Becker H, Bredereke-Wiedling H, de Weerth A, Paschen HR, Sheikhzadeh-Eggers S, Stang A, Schmiedel S, Bokemeyer C, Addo MM, Aepfelbacher M, Püschel K, Kluge S (2020) Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann Intern Med 173(4):268–277CrossRef
4.
go back to reference Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395(10234):1417–1418CrossRef Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395(10234):1417–1418CrossRef
5.
go back to reference Edler C, Schröder AS, Aepfelbacher M, Fitzek A, Heinemann A, Heinrich F, Klein A, Langenwalder F, Lütgehetmann M, Meißner K, Püschel K, Schädler J, Steurer S, Mushumba H, Sperhake JP (2020) Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int J Legal Med 134(4):1275–1284CrossRef Edler C, Schröder AS, Aepfelbacher M, Fitzek A, Heinemann A, Heinrich F, Klein A, Langenwalder F, Lütgehetmann M, Meißner K, Püschel K, Schädler J, Steurer S, Mushumba H, Sperhake JP (2020) Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int J Legal Med 134(4):1275–1284CrossRef
6.
go back to reference Sriwijitalai W, Wiwanitkit V (2020) COVID-19 in forensic medicine unit personnel: observation from Thailand. J Forensic Legal Med 72:101964CrossRef Sriwijitalai W, Wiwanitkit V (2020) COVID-19 in forensic medicine unit personnel: observation from Thailand. J Forensic Legal Med 72:101964CrossRef
7.
go back to reference Sriwijitalai W, Wiwanitkit V (2020) Corrigendum to “COVID-19 in forensic medicine unit personnel: observation from Thailand”. J Forensic Legal Med 72:101967CrossRef Sriwijitalai W, Wiwanitkit V (2020) Corrigendum to “COVID-19 in forensic medicine unit personnel: observation from Thailand”. J Forensic Legal Med 72:101967CrossRef
8.
go back to reference Arons MM, Hatfield KM, Reddy SC, Kimball A, James A, Jacobs JR, Taylor J, Spicer K, Bardossy AC, Oakley LP, Tanwar S, Dyal JW, Harney J, Chisty Z, Bell JM, Methner M, Paul P, Carlson CM, McLaughlin H, Thornburg N, Tong S, Tamin A, Tao Y, Uehara A, Harcourt J, Clark S, Brostrom-Smith C, Page LC, Kay M, Lewis J, Montgomery P, Stone ND, Clark TA, Honein MA, Duchin JS, Jernigan JA, Public Health–Seattle and King County and CDC COVID-19 Investigation Team (2020) Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med 382:2081–2090CrossRef Arons MM, Hatfield KM, Reddy SC, Kimball A, James A, Jacobs JR, Taylor J, Spicer K, Bardossy AC, Oakley LP, Tanwar S, Dyal JW, Harney J, Chisty Z, Bell JM, Methner M, Paul P, Carlson CM, McLaughlin H, Thornburg N, Tong S, Tamin A, Tao Y, Uehara A, Harcourt J, Clark S, Brostrom-Smith C, Page LC, Kay M, Lewis J, Montgomery P, Stone ND, Clark TA, Honein MA, Duchin JS, Jernigan JA, Public Health–Seattle and King County and CDC COVID-19 Investigation Team (2020) Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med 382:2081–2090CrossRef
9.
go back to reference Singanayagam A, Patel M, Charlett A, Lopez BJ, Saliba V, Ellis J et al (2020) Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Euro Surveill 25(32):2001483CrossRef Singanayagam A, Patel M, Charlett A, Lopez BJ, Saliba V, Ellis J et al (2020) Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Euro Surveill 25(32):2001483CrossRef
10.
go back to reference Wölfel R, Corman VM, Guggemos W, Seimaier M, Zange S, Müller MA et al (2020) Virological assessment of hospitalized patients with COVID-2019. Nature 581:465–469CrossRef Wölfel R, Corman VM, Guggemos W, Seimaier M, Zange S, Müller MA et al (2020) Virological assessment of hospitalized patients with COVID-2019. Nature 581:465–469CrossRef
11.
go back to reference La Scola B, Le Bideau M, Andreani J, Hoang VT, Grimaldier C, Colson P et al (2020) Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis 39(6):1059–1061CrossRef La Scola B, Le Bideau M, Andreani J, Hoang VT, Grimaldier C, Colson P et al (2020) Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis 39(6):1059–1061CrossRef
12.
go back to reference Jachau K (2015) Thanatology. In: Madea B (ed) Rechtsmedizin, 3rd edn. Springer, Berlin/Heidelberg, pp 72–76 Jachau K (2015) Thanatology. In: Madea B (ed) Rechtsmedizin, 3rd edn. Springer, Berlin/Heidelberg, pp 72–76
13.
go back to reference Matson M, Yinda C, Seifert SN, Bushmaker T, Fischer RJ, van Doremalen N et al (2020) Effect of environmental conditions on SARS-CoV-2 stability in human nasal mucus and sputum. Emerg Infect Dis 26(9):2276–2278CrossRef Matson M, Yinda C, Seifert SN, Bushmaker T, Fischer RJ, van Doremalen N et al (2020) Effect of environmental conditions on SARS-CoV-2 stability in human nasal mucus and sputum. Emerg Infect Dis 26(9):2276–2278CrossRef
14.
go back to reference Wang J, Du G (2020) COVID-19 may transmit through aerosol. Ir J Med Sci 189(4):1143–1144CrossRef Wang J, Du G (2020) COVID-19 may transmit through aerosol. Ir J Med Sci 189(4):1143–1144CrossRef
15.
go back to reference Hanley B, Lucas SB, Youd E, Swift B, Osborn M (2020) Autopsy in suspected COVID-19 cases. J Clin Pathol 73(5):239–242CrossRef Hanley B, Lucas SB, Youd E, Swift B, Osborn M (2020) Autopsy in suspected COVID-19 cases. J Clin Pathol 73(5):239–242CrossRef
Metadata
Title
Infectivity of deceased COVID-19 patients
Authors
Stefanie Plenzig
D. Bojkova
H. Held
A. Berger
F. Holz
J. Cinatl
E. Gradhand
M. Kettner
A. Pfeiffer
M. A. Verhoff
S. Ciesek
Publication date
01-09-2021
Publisher
Springer Berlin Heidelberg
Published in
International Journal of Legal Medicine / Issue 5/2021
Print ISSN: 0937-9827
Electronic ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-021-02546-7

Other articles of this Issue 5/2021

International Journal of Legal Medicine 5/2021 Go to the issue